OPR - Delayed Quote • USD CYTK Apr 2024 58.000 put (CYTK240426P00058000) Follow 2.3000 0.0000 (0.00%) At close: March 19 at 1:53 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for CYTK240426P00058000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: CYTK Cytokinetics to Announce First Quarter Results on May 8, 2024 This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives? Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress EVP Research & Development Fady Malik Sells Shares of Cytokinetics Inc (CYTK) Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session 2 Incredible Growth Stocks to Buy Right Now 7 Biotech Stocks Ready to Ride the Sector’s Resurgence 30 Biggest Biotechnology Companies in the World 7 Biotech Stocks to Buy as Sector Rotation Ramps Up
